Shopping Cart
- Remove All
- Your shopping cart is currently empty
MK2-IN-6 (Compound 11) is an effective and selective irreversible inhibitor of MK2 with an IC50 value of 2.3 nM. It suppresses the kinase activity of MK2, leading to sustained inhibition of MK2 signaling and reduction of pathological inflammatory factors in macrophages. MK2-IN-6 is capable of inhibiting the M2-like protein phenotype in macrophages both in vitro and in vivo, showing potential for use in colorectal cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | MK2-IN-6 (Compound 11) is an effective and selective irreversible inhibitor of MK2 with an IC50 value of 2.3 nM. It suppresses the kinase activity of MK2, leading to sustained inhibition of MK2 signaling and reduction of pathological inflammatory factors in macrophages. MK2-IN-6 is capable of inhibiting the M2-like protein phenotype in macrophages both in vitro and in vivo, showing potential for use in colorectal cancer research. |
Targets&IC50 | MK5:>100 nM, FGFR4:>1000 nM, MK3:>100 nM, TTK:>1000 nM, p70S6Kb:>1000 nM, p38:>1000 nM |
In vitro | MK2-IN-6 exhibits high selectivity and irreversible inhibition of MK2, similar to PF-3644022, with an inhibitory concentration of 2.3 nM over 70 minutes. At concentrations ranging from 1-10 μM for 1.5 or 6 hours, MK2-IN-6 profoundly suppresses transcription and production of cytokines in macrophages by targeting classical downstream genes associated with MK2. |
In vivo | Administered at a dosage of 10 mg/kg through intraperitoneal injection twice daily for a duration of 12 days, MK2-IN-6 significantly inhibited tumor growth in mice with the MC38 tumor model. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.